Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers February 21, 2019
Pharmacy Choice - Pharmaceutical News - Fervent Pharmaceuticals Completes Clinical Trial For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms - February 21, 2019

Pharmacy News Article

 11/14/18 - Fervent Pharmaceuticals Completes Clinical Trial For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms

GREENVILLE, N.C., Nov. 14, 2018 /PRNewswire/ Fervent Pharmaceuticals of Greenville, N.C. has successfully completed its Phase 2A clinical trial for FP-101, a new therapy developed to treat the vasomotor symptoms associated with menopause, like hot flashes and night sweats.

The two-month clinical trial included 112 women in North Carolina, South Carolina, Illinois, and Tennessee. Fervent partnered with Winston-Salem-based PMG Research to recruit patients and conduct the trial.

"Completing this clinical trial brings us one step closer to achieving our mission, which is to better women's lives through new therapies for menopausal symptoms," George Royster, founder of Fervent Pharmaceuticals, said. "Night sweats and hot flashes interrupt the everyday lives of women, and we're addressing those symptoms through FP-101."

The therapy in trial is an orally dosed, non-hormonal, non-herbal, non-antidepressant formulation of a compound that has known mechanisms of action, is already FDA-approved for another undisclosed indication, and has a long history of safe use.

FP-101 demonstrated a 90% efficacy rate in its pilot study, and Fervent expects similar results to emerge from the clinical trial when the data has been fully analyzed.

Fervent is able to utilize the FDA's simpler application process for a new indication rather than the full application for a new compound. This expedited process, which uses prior research on the compound, will shorten application time and lower the costs associated with bringing FP-101 to market.

Fervent Pharmaceuticals is a clinical stage drug development company founded in North Carolina in 2011. It is focused on improving women's quality of life by developing therapies targeting unmet needs in women's health. Learn more at

Cision View original content:

SOURCE Fervent Pharmaceuticals

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Feb 22: Medical Marijuana: The Basic and Clinical Pharmacology, Not The Politics
Feb 24: A Primer to Paleo
Feb 25: Obesity Management: Overview of Pharmacotherapy
Feb 26: Mobile Applications for Pharmacists: Tools That Help Pharmacies be Successful
Feb 28: Beyond the Biome- Managing Gut Health Through Lifestyle Medicine
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement